Portage Biotech Stock Price on December 2, 2024
PRTG Stock | USD 4.18 0.03 0.71% |
Below is the normalized historical share price chart for Portage Biotech extending back to July 27, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Portage Biotech stands at 4.18, as last reported on the 2nd of December, with the highest price reaching 4.53 and the lowest price hitting 4.09 during the day.
If you're considering investing in Portage Stock, it is important to understand the factors that can impact its price. Portage Biotech is dangerous given 3 months investment horizon. Portage Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.0673, which implies the firm had a 0.0673% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.15% are justified by taking the suggested risk. Use Portage Biotech Coefficient Of Variation of 4656.65, risk adjusted performance of 0.026, and Semi Deviation of 10.48 to evaluate company specific risk that cannot be diversified away.
At this time, Portage Biotech's Stock Based Compensation is most likely to increase significantly in the upcoming years. The Portage Biotech's current Issuance Of Capital Stock is estimated to increase to about 9.9 M, while Liabilities And Stockholders Equity is projected to decrease to roughly 7.4 M. . The current Price To Sales Ratio is estimated to decrease to 1,972. The current Price Earnings Ratio is estimated to decrease to -3.14. Portage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of February 2021 | 200 Day MA 6.1013 | 50 Day MA 5.6839 | Beta 99.478 |
Portage |
Sharpe Ratio = 0.0673
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | PRTG | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
17.02 actual daily | 96 96% of assets are less volatile |
Expected Return
1.15 actual daily | 22 78% of assets have higher returns |
Risk-Adjusted Return
0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Portage Biotech is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Portage Biotech by adding it to a well-diversified portfolio.
Price Book 3.356 | Book Value 4.066 | Enterprise Value 3 M | Enterprise Value Ebitda (0.02) | Shares Float 595.2 K |
Portage Biotech Valuation on December 2, 2024
It is possible to determine the worth of Portage Biotech on a given historical date. On December 2, 2024 Portage was worth 4.2 at the beginning of the trading date compared to the closed value of 4.18. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Portage Biotech stock. Still, in general, we apply an absolute valuation method to find Portage Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Portage Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Portage Biotech's related companies.
Open | High | Low | Close | Volume | |
4.20 | 4.53 | 4.09 | 4.18 | 15,084 | |
12/02/2024 | 4.20 | 4.53 | 4.09 | 4.18 | 0.00 |
Backtest Portage Biotech | | | Portage Biotech History | | | Portage Biotech Valuation | Previous |
Portage Biotech Trading Date Momentum on December 2, 2024
On December 02 2024 Portage Biotech was traded for 4.18 at the closing time. The top price for the day was 4.53 and the lowest listed price was 4.09 . There was no trading activity during the period 0.0. Lack of trading volume on December 2, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.48% . |
Portage Biotech Fundamentals Correlations and Trends
By evaluating Portage Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Portage Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Portage financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Portage Biotech Stock history
Portage Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Portage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Portage Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Portage Biotech stock prices may prove useful in developing a viable investing in Portage Biotech
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 20.3 M | 21.4 M | |
Net Loss | -15.2 M | -14.4 M |
Portage Biotech Quarterly Net Working Capital |
|
Portage Biotech Stock Technical Analysis
Portage Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Portage Biotech Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Portage Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Portage Biotech December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Portage Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Portage Biotech shares will generate the highest return on investment. By undertsting and applying Portage Biotech stock market strength indicators, traders can identify Portage Biotech entry and exit signals to maximize returns
Portage Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Portage Biotech's price direction in advance. Along with the technical and fundamental analysis of Portage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Portage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.026 | |||
Jensen Alpha | 0.4834 | |||
Total Risk Alpha | (2.56) | |||
Sortino Ratio | 0.0221 | |||
Treynor Ratio | (0.40) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Portage Stock analysis
When running Portage Biotech's price analysis, check to measure Portage Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Portage Biotech is operating at the current time. Most of Portage Biotech's value examination focuses on studying past and present price action to predict the probability of Portage Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Portage Biotech's price. Additionally, you may evaluate how the addition of Portage Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |